RACING Trial: Rethinking LDL-C Lowering in ASCVD
Explore the RACING trial and its subgroup analyses comparing moderate-intensity statin + ezetimibe combination therapy with high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease.
Content exclusive for connected users. Please sign in or register to access more.
Already have an account?
Sign inNew here?
Create account